D.E. Shaw & Co
IART icon

D.E. Shaw & Co’s Integra LifeSciences IART Stock Holding History

D.E. Shaw & Co’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$893K – 4098
2020
Q1 		$893K Buy
+20,000
New +$1.05M ﹤0.01% 2819

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

D.E. Shaw & Co's IART Position: Q2 2026 in Review

D.E. Shaw & Co increased its Integra LifeSciences (IART) stake by 30% in Q2 2026, buying an estimated $1.65M and bringing the position to 507,252 shares worth $9.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

D.E. Shaw & Co first reported a position in IART in Q4 2013 and has held it in 50 quarters since. The position peaked at $33M in Q2 2018. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • D.E. Shaw & Co held 507,252 shares of Integra LifeSciences worth $9.11M as of Q2 2026.
  • D.E. Shaw & Co bought 117,753 Integra LifeSciences shares in Q2 2026, an estimated $1.65M.
  • Integra LifeSciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1895 holding.
  • D.E. Shaw & Co first reported a position in Integra LifeSciences in Q4 2013 and has held it in 50 quarters since.
  • D.E. Shaw & Co's Integra LifeSciences position peaked at $33M in Q2 2018.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.